Coya Therapeutics, Inc. (COYA) Insider Ownership

Historic Insider Ownership Trends

According to recent filings covering the 90 days ending February 19, 2026, the three most significant insider holders at Coya Therapeutics are Director Dov A Md Goldstein (27.56K shares), Chief Executive Officer Howard Berman (10.00K shares), Director Anabella Villalobos (10.00K shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares Report Date
Dov A Md Goldstein 27,557 19 Aug, 2025
Adrian Hepner Chief Medical Officer 10,000 04 Jan, 2023
Arun Swaminathan Chief Executive Officer 10,000 13 Nov, 2024
Anabella Villalobos 10,000 04 Jan, 2023
Howard Berman Chief Executive Officer 10,000 04 Jan, 2023
David S Snyder Chief Financial Officer 8,800 14 Nov, 2024
Fred Grossman Chief Medical Officer 2,710 12 Nov, 2024
Hideki Garren 2,000 04 Jan, 2023

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
18 Aug, 2025 Dov A Md Goldstein Common Stock, par value $0.0001 per share A 17,557 $1.09 27,557 D M
14 Nov, 2024 David S Snyder Common Stock, par value $0.0001 per share A 1,800 $7.19 8,800 D P
14 Nov, 2024 David S Snyder - - 8,800 D
13 Nov, 2024 Arun Swaminathan Common Stock, par value $0.0001 per share A 5,000 $7.36 10,000 D P
11 Nov, 2024 Fred Grossman - - 2,710 D
11 Nov, 2024 Fred Grossman Common Stock, par value $0.0001 per share A 2,710 $7.37 2,710 D P
11 Nov, 2024 Arun Swaminathan Common Stock, par value $0.0001 per share A 5,000 $7.34 5,000 D P
03 Jan, 2023 Dov A Md Goldstein Common Stock, par value $0.0001 per share A 10,000 - 10,000 D P
03 Jan, 2023 David S Snyder Common Stock, par value $0.0001 per share A 7,000 - 7,000 D P
03 Jan, 2023 Adrian Hepner Common Stock, par value $0.0001 per share A 10,000 - 10,000 D P
03 Jan, 2023 Hideki Garren Common Stock, par value $0.0001 per share A 2,000 - 2,000 D P
03 Jan, 2023 Anabella Villalobos - - 10,000 D
03 Jan, 2023 Anabella Villalobos Common Stock, par value $0.0001 per share A 10,000 - 10,000 D P
03 Jan, 2023 Howard Berman Common Stock, par value $0.0001 per share A 10,000 - 10,000 D P